Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal modelsHan-Yi Huang, Chi‐Huey Wong, Yimin Wu et al.|Science Translational Medicine|2022Cited by 127
Domain requirement of moenomycin binding to bifunctional transglycosylases and development of high-throughput discovery of antibioticsTing-Jen Rachel Cheng, Wei‐Chieh Cheng, Ming-Ta Sung et al.|Proceedings of the National Academy of Sciences|2008Cited by 75
Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypesHsin-Yu Liao, Chi‐Huey Wong, Shih-Chi Wang et al.|Proceedings of the National Academy of Sciences|2020Cited by 38
A non-neutralizing antibody broadly protects against influenza virus infection by engaging effector cellsYi‐An Ko, Kuo‐I Lin, Yueh‐Hsiang Yu et al.|PLoS Pathogens|2021Cited by 37
Impact of glycosylation on a broad-spectrum vaccine against SARS-CoV-2Han-Yi Huang, Chi‐Huey Wong, Hsin-Yu Liao et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 3